SCOPUS 정보 검색 플랫폼

Volumn 89, Issue 3, 2000, Pages 516-522

Treatment of patients with advanced nonsmall cell lung carcinoma using docetaxel and gemcitabine plus granulocyte-colony stimulating factor

(9) Hejna, Michael a Kornek, Gabriela V a Raderer, Markus a Ulrich Pur, Herbert a Fiebiger, Wolfgang C C a Marosi, Leo b Schneeweiss, Bruno b Greul, Rosemarie b Scheithauer, Werner a

a UNIVERSITY OF VIENNA (Austria)

b MEDICAL UNIVERSITY OF VIENNA (Austria)

Author keywords

Advanced nonsmall cell lung carcinoma (NSCLC); Docetaxel; Gemcitabine; Granulocyte colony stimulating factor (G CSF)

Indexed keywords

DOCETAXEL; GEMCITABINE; GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; ADVANCED CANCER; AGED; ARTICLE; BONE MARROW SUPPRESSION; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; DRUG TOLERABILITY; FATIGUE; FEMALE; GRANULOCYTOPENIA; HUMAN; LEUKOPENIA; LUNG NON SMALL CELL CANCER; MALE; NAUSEA; PRIORITY JOURNAL; SURVIVAL TIME; TREATMENT OUTCOME;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, NON-SMALL-CELL LUNG; DEOXYCYTIDINE; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PACLITAXEL; SURVIVAL ANALYSIS; TAXOIDS;

EID: 0034255161 PISSN: 0008543X EISSN: None Source Type: Journal
DOI: 10.1002/1097-0142(20000801)89:3<516::AID-CNCR6>3.0.CO;2-9 Document Type: Article

Times cited : (34)

References (37)

1
- 0033006836
- Cancer statistics, 1999
- (1999) CA Cancer J Clin , vol.49 , pp. 8-31
- Landis, S.H.¹ Murray, T.² Bolden, S.³ Wingo, P.A.⁴

2
- 0026440636
- Chemotherapy of lung cancer
- (1992) N Engl J Med , vol.337 , pp. 1434-1441
- Ihde, D.C.¹

3
- 0002384775
- Non-small cell lung cancer
- DeVita VT Jr., Hellmann S, Rosenberg SA, editors. Cancer: Principles and practice of oncology. 4th ed. Philadelphia: JB Lippincott
- (1993) , pp. 673-758
- Ginsberg, R.J.¹ Kris, M.G.² Armstrong, J.G.³

4
- 0027210487
- Polychemotherapy in advanced non-small cell lung cancer: A meta-analysis
- (1993) Lancet , vol.342 , pp. 19-21
- Souquet, P.J.¹ Chauvin, F.² Boissel, J.P.³ Cellerino, R.⁴ Cormier, Y.⁵ Ganz, P.A.⁶

5
- 0027367248
- Chemotherapy for advanced non-small-cell lung cancer: How much benefit is enough?
- (1993) J Clin Oncol , vol.11 , pp. 1866-1872
- Grilli, R.¹ Oxman, A.D.² Julian, J.A.³

6
- 0028031433
- Chemotherapy versus supportive care in advanced non-small cell lung cancer: Results of a meta-analysis of the literature
- (1994) Chest , vol.106 , pp. 861-865
- Marino, P.¹ Pampallona, S.² Preatoni, A.³ Cantoni, A.⁴ Invernizzi, F.⁵

7
- 0000049913
- A meta-analysis using individual patient data from randomized clinical trials of chemotherapy in non-small cell lung cancer: Survival in the supportive care setting
- (1994) Proc Am Soc Clin Oncol , vol.13 , pp. 337
- Stewart, L.A.¹ Pignon, J.P.² Parmar, A.K.B.³ Bijnens, L.⁴ Clarke, J.⁵ Franks, G.⁶

8
- 0028843552
- Non-Small Cell Lung Cancer Collaborative Group. Chemotherapy in non-small cell lung cancer: A meta-analysis using updated data on individual patients
- (1995) BMJ , vol.311 , pp. 899-909

9
- 0028169602
- Docetaxel (Taxotere) is active in non-small cell lung cancer: A phase II trial of the EORTC Early Clinical Trial group (ECTG)
- (1994) Br J Cancer , vol.70 , pp. 384-387
- Cerny, T.¹ Kaplan, S.² Pavlidis, N.³ Schoffski, P.⁴ Epelbaum, R.⁵ Van Meerbeek, J.⁶

10
- 0028240902
- Phase II trial of docetaxel in patients with stage III and IV non-small cell lung cancer
- (1994) J Clin Oncol , vol.12 , pp. 1232-1237
- Francis, P.A.¹ Rigas, J.R.² Kris, M.G.³ Pisters, K.M.⁴ Orazem, J.P.⁵ Woolley, K.J.⁶

11
- 0028896128
- 2 dose of docetaxel with prednisone premedication for patients with advanced non-small cell lung cancer
- (1995) Cancer , vol.75 , pp. 968-972
- Miller, V.A.¹ Rigas, J.R.² Francis, P.A.³ Grant, S.C.⁴ Pisters, K.M.⁵ Venkatraman, E.S.⁶

12
- 23444459189
- Phase II trial of docetaxel for recurrent or metastatic non-small cell lung cancer
- (1994) J Clin Oncol , vol.12 , pp. 1238-1244
- Fossella, F.V.¹ Lee, J.S.² Murphy, W.K.³ Lippman, S.M.⁴ Calayag, M.⁵ Pang, A.⁶

13
- 0028033227
- Single agent activity of weekly gemcitabine in advanced non-small cell lung cancer. A phase II study
- (1994) J Clin Oncol , vol.12 , pp. 1821-1826
- Anderson, H.¹ Lund, B.² Bach, F.³ Thatcher, N.⁴ Walling, J.⁵ Hansen, H.H.⁶

14
- 0029914387
- Activity of gemcitabine in patients with non-small cell lung cancer. A multi-center, extended phase II study
- (1996) Eur J Cancer , vol.32 A , pp. 243-248
- Gatzemeier, U.¹ Shepherd, F.A.² Le Chevalier, T.³ Weynants, P.⁴ Cottier, B.⁵ Groen, H.J.⁶

15
- 0028022127
- Gemcitabine: Current status of phase I and II trials
- (1994) J Clin Oncol , vol.12 , pp. 1527-1531
- Kaye, S.B.¹

16
- 0028847005
- Gemcitabine in the treatment of non-small cell lung cancer
- (1995) Ann Oncol , vol.6 , Issue.SUPPL. 3
- Burkes, R.L.¹ Shepard, F.A.²

17
- 0029809541
- Gemcitabine: Preclinical pharmacology and mechanism of action
- (1996) Semin Oncol , vol.23 , Issue.SUPPL. 10 , pp. 3-15
- Plunkett, W.¹ Huang, P.² Searcy, C.E.³ Gandhi, V.⁴

18
- 0028999349
- S-phase specificity of cell killing by docetaxel (Taxotere) in synchronized HeLa cells
- (1995) Br J Cancer , vol.71 , pp. 1194-1198
- Hennequinn, C.¹ Giocanti, N.² Favaudon, V.³

19
- 0013580669
- Weekly gemcitabine combined with monthly docetaxel in patients with advanced malignances: A phase I trial
- (1998) Proc Am Soc Clin Oncol , vol.17
- Spironidis, C.H.¹ Laufmann, L.R.² Jones, J.J.³ Feiglin, D.⁴ Collins, G.H.⁵ Sonderegger, P.⁶

20
- 0008438352
- Phase I dose-escalation study of constant rate infusion gemcitabine in combination with Taxotere in advanced non-small cell lung cancer
- (1998) Proc Am Clin Oncol , vol.17
- Garland, L.L.¹ Wagner, H.² Shaw, G.S.³ Franklin, B.A.⁴ Kapler, C.R.⁵ Tinley, S.T.⁶

21
- 24044504049
- editors. Lung AJCC Cancer Staging Manual. 5th ed. Philadelphia: Lippincott-Raven
- (1997) , pp. 127-137
- Fleming, I.D.¹ Cooper, J.S.² Henson, D.E.³ Hutter, R.V.P.⁴ Kennedy, B.J.⁵ Murphy, G.P.⁶

22
- 50549174560
- The determination of the number of patients required in a follow-up trial of a new chemotherapeutic agent
- (1961) J Chron Dis , vol.13 , pp. 346-353
- Gehan, E.A.¹

23
- 33845382806
- Non-parametric estimation from incomplete observations
- (1959) J Am Stat Assoc , vol.53 , pp. 457-481
- Kaplan, E.L.¹ Meier, P.²

24
- 0008514859
- The analysis of binary data. London: Methuen
- Cox, D.R.¹

25
- 0031823199
- Do newer chemotherapeutic agents improve survival in non-small cell lung cancer?
- (1998) Semin Oncol , vol.25 , pp. 5-9
- Rigas, J.R.¹

26
- 0002118197
- New clinical strategies in non-small-cell lung cancer
- Oncology , vol.13 , pp. 60-64
- Greco, F.A.¹

27
- 0000324102
- A phase I trial of gemcitabine and paclitaxel in patients with recurrent epithelial ovarian cancer
- (1996) Ann Oncol , vol.7
- Poole, C.J.¹ Cook, J.² Hogberg, T.³ Fankhauser, C.⁴ Li, J.⁵ Nagpal, P.⁶

28
- 0001312103
- A phase I study to investigate alternate sequencing of the combination of gemcitabine and paclitaxel in ovarian carcinoma
- (1997) Eur J Cancer , vol.33 , Issue.SUPPL. 8 , pp. 543
- Poole, C.J.¹ Perren, T.² Hogberg, T.³ Loder, C.⁴ Soballe, B.⁵ Stafford, G.P.⁶

29
- 0000588220
- Preliminary results from an early phase II combination of gemcitabine and taxol in metastatic breast cancer
- (1997) Eur J Cancer , vol.33 , Issue.SUPPL. 8 , pp. 685
- Sanchez-Rovira, P.¹ Mohedano, N.² Moreno, M.A.³ Gaya, P.⁴ Medina, M.⁵ Nunez, M.⁶

30
- 0033014303
- Front-line treatment of advanced non-small cell lung cancer with docetaxel and gemcitabine: A multicenter phase II trial
- (1999) J Clin Oncol , vol.17 , pp. 914-920
- Georgoulias, V.¹ Kouroussis, C.² Androulakis, N.³ Kakolyris, S.⁴ Dimopoulos, M.A.⁵ Papadakis, E.⁶

31
- 0029911655
- Five-day course of granulocyte colony-stimulating factor in patients with prolonged neutropenia after adjuvant chemotherapy for breast cancer is a safe and cost-effective schedule to maintain dose-intensity
- (1996) J Clin Oncol , vol.14 , pp. 1573-1580
- Ribas, A.¹ Albanell, J.² Bellmunt, J.³ Sole-Calvo, L.A.⁴ Bermejo, B.⁵ Gallardo, E.⁶

32
- 0025735389
- A randomized trial of five cisplatin-containing treatments in patients with metastatic non-small cell lung cancer. A Southwest Oncology Group study
- (1991) J Clin Oncol , vol.9 , pp. 1157-1167
- Weick, J.K.¹ Crowley, J.² Natale, R.B.³ Hom, B.L.⁴ Rivkin, S.⁵ Coltman C.A., Jr.⁶

33
- 0023803989
- Mitomycin, ifosfamide and cisplatin in non-small cell lung cancer: Treatment good enough to compare
- (1988) Br J Cancer , vol.58 , pp. 359-361
- Cullen, M.H.¹ Joshi, R.² Chetiyawardana, A.D.³ Woodroffe, C.M.⁴

34
- 0028154069
- Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small cell lung cancer. Results of a European multicenter trial including 612 patients
- (1994) J Clin Oncol , vol.12 , pp. 360-367
- Le Chevalier, T.¹ Brisgand, D.² Douillard, J.Y.³ Pujol, J.L.⁴ Alberola, V.⁵ Monnier, A.⁶

35
- 7144229342
- First-line treatment of advanced non-small cell lung cancer with docetaxel and cisplatin: A multicenter phase II study
- (1998) Ann Oncol , vol.9 , pp. 331-334
- Georgoulias, V.¹ Androulakis, N.² Dimopoulos, M.A.³ Kourousis, C.⁴ Kakolyris, S.⁵ Papadakis, E.⁶

36
- 0000548953
- E1594-A randomized phase III trial in metastatic non-small cell lung cancer (NSCLC) - Outcome of PS 2 patients (Pts): An Eastern Cooperative Group Trial
- (1999) Proc Am Soc Clin Oncol , vol.18
- Johson, D.H.¹ Zhu, J.² Schiller, J.³ Belani, C.P.⁴ Langer, C.⁵ Krook, J.⁶

37
- 0000421455
- Docetaxel plus gemcitabine chemotherapy in advanced non-small cell lung cancer: A preliminary analysis of a multicenter randomized phase II trial
- (1999) Proc Am Soc Clin Oncol , vol.18
- Georgoulias, V.¹ Papadakis, E.² Alexopoulus, A.³ Stavrindis, E.⁴ Bania, E.⁵ Rapti, A.⁶

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.